Skip to main content

Table 1 Patient information

From: Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve disease

Characteristic

Control (n = 6)

MMVD (n = 58)

Age (yrs)

2.667 ± 1.033

12.89 ± 2.378

Sex, n (%)

 Male

2 (33%)

4 (7%)

 Male castrated

2 (33%)

25 (43%)

 Female

0 (0%)

5 (9%)

 Female spayed

2 (33%)

24 (41%)

BCS (9-point scale)

5.333 ± 0.5164

4.641 ± 1.462

Weight (kg)

33.18 ± 8.292

4.265 ± 2.048

Murmur (6-point scale)

0

4.125 ± 0.787

Death, n (%)

0

8 (13.8%)

Stage (sampling counts)

 B1

 

15 (15)

 B2

 

20 (21)

 C

 

19 (19)

 D

 

4 (9)

Comorbidity

 None

 

28 (48%)

 CKD

 

26 (44%)

 Chronic pancreatitis

 

9 (15%)

 Etc

 

8 (13%)

  1. All data are expressed as mean ± SD value
  2. Abbreviations: BCS Body condition score, CKD Chronic kidney disease, MMVD Myxomatous mitral valve disease